Verition Fund Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-130,893
Closed -$1.9M 3557
2025
Q3
$1.9M Buy
130,893
+89,284
+215% +$1.27M 0.01% 2023
2025
Q2
$813K Buy
+41,609
New +$739K ﹤0.01% 2622
2024
Q4
Sell
-19,410
Closed -$606K 3266
2024
Q3
$606K Buy
19,410
+2,670
+16% +$66.4K ﹤0.01% 2204
2024
Q2
$260K Buy
16,740
+5,185
+45% +$62.7K ﹤0.01% 2436
2024
Q1
$122K Buy
+11,555
New +$116K ﹤0.01% 2559
2023
Q3
Sell
-30,995
Closed -$263K 2377
2023
Q2
$263K Buy
30,995
+15,900
+105% +$133K ﹤0.01% 1658
2023
Q1
$138K Buy
+15,095
New +$193K ﹤0.01% 1861
2021
Q4
Sell
-10,531
Closed -$667K 2566
2021
Q3
$667K Buy
10,531
+4,257
+68% +$324K 0.01% 1095
2021
Q2
$574K Buy
+6,274
New +$499K 0.01% 1031

Other funds holding CDNA

Verition Fund Management's CDNA Position: Q4 2025 in Review

Verition Fund Management sold out of CareDx (CDNA) in Q4 2025, closing a stake of 130,893 shares — an estimated $1.9M sold.

Verition Fund Management first reported a position in CDNA in Q2 2021 and held it in 9 quarters. The position peaked at $1.9M in Q3 2025. 200 funds tracked by Wall St. Rank hold CDNA as of Q4 2025.

  • Verition Fund Management reported no remaining CareDx position as of Q4 2025 after selling out during the quarter.
  • Verition Fund Management sold 130,893 CareDx shares in Q4 2025, an estimated $1.9M.
  • Verition Fund Management first reported a position in CareDx in Q2 2021 and held it in 9 quarters.
  • Verition Fund Management's CareDx position peaked at $1.9M in Q3 2025.
  • 200 funds tracked by Wall St. Rank held CareDx as of Q4 2025.

Based on Verition Fund Management's 13F filing for Q4 2025, filed 13 Feb 2026.